170 related articles for article (PubMed ID: 12471877)
21. Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors.
Motzer RJ; Amsterdam A; Prieto V; Sheinfeld J; Murty VV; Mazumdar M; Bosl GJ; Chaganti RS; Reuter VE
J Urol; 1998 Jan; 159(1):133-8. PubMed ID: 9400455
[TBL] [Abstract][Full Text] [Related]
22. Poor-risk germ cell tumors. Recent developments.
Dodd PM; Motzer RJ; Bajorin DF
Urol Clin North Am; 1998 Aug; 25(3):485-93. PubMed ID: 9728218
[TBL] [Abstract][Full Text] [Related]
23. Testicular germ-cell cancer.
Bosl GJ; Motzer RJ
N Engl J Med; 1997 Jul; 337(4):242-53. PubMed ID: 9227931
[No Abstract] [Full Text] [Related]
24. Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration.
Giannatempo P; Pond GR; Sonpavde G; Albany C; Loriot Y; Sweeney CJ; Salvioni R; Colecchia M; Nicolai N; Raggi D; Rice KR; Flack CK; El Mouallem NR; Feldman H; Fizazi K; Einhorn LH; Foster RS; Necchi A; Cary C
J Urol; 2016 Jul; 196(1):95-100. PubMed ID: 26748165
[TBL] [Abstract][Full Text] [Related]
25. [Long-term results of laparoscopic retroperitoneal lymph node dissection (RPLND) in low-stage nonseminomatous germ-cell testicular tumors (NSGCTT) performed by a senior surgeon: 1999-2003].
Pizzocaro G; Schiavo M; Solima S; Vitellaro M; Biasoni N; Nicolai N
Urologia; 2010; 77 Suppl 17():50-6. PubMed ID: 21308676
[TBL] [Abstract][Full Text] [Related]
26. Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: a single-center 10-year experience.
Gels ME; Hoekstra HJ; Sleijfer DT; Marrink J; de Bruijn HW; Molenaar WM; Freling NJ; Droste JH; Schraffordt Koops H
J Clin Oncol; 1995 May; 13(5):1188-94. PubMed ID: 7537802
[TBL] [Abstract][Full Text] [Related]
27. [Progress in the treatment of germ cell tumor of the testis].
Villavicencio Mavrich H
Actas Urol Esp; 2002; 26(10):759-62. PubMed ID: 12645372
[TBL] [Abstract][Full Text] [Related]
28. Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome.
McKiernan JM; Motzer RJ; Bajorin DF; Bacik J; Bosl GJ; Sheinfeld J
Urology; 2003 Oct; 62(4):732-6. PubMed ID: 14550453
[TBL] [Abstract][Full Text] [Related]
29. Management, Treatment, and Molecular Background of the Growing Teratoma Syndrome.
Hiester A; Nettersheim D; Nini A; Lusch A; Albers P
Urol Clin North Am; 2019 Aug; 46(3):419-427. PubMed ID: 31277736
[TBL] [Abstract][Full Text] [Related]
30. Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach.
Sonneveld DJ; Sleijfer DT; Koops HS; Keemers-Gels ME; Molenaar WM; Hoekstra HJ
Cancer; 1998 Apr; 82(7):1343-51. PubMed ID: 9529027
[TBL] [Abstract][Full Text] [Related]
31. Recent developments in the management of testicular germ cell tumors.
Chin JL
Can J Urol; 2000 Aug; 7(4):1060-5. PubMed ID: 11109075
[TBL] [Abstract][Full Text] [Related]
32. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
[TBL] [Abstract][Full Text] [Related]
33. Incidence and clinical outcome of patients with teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and IIA nonseminomatous germ cell tumors.
Sheinfeld J; Motzer RJ; Rabbani F; McKiernan J; Bajorin D; Bosl GJ
J Urol; 2003 Oct; 170(4 Pt 1):1159-62. PubMed ID: 14501715
[TBL] [Abstract][Full Text] [Related]
34. Modeling the cost of management options for stage I nonseminomatous germ cell tumors: a decision tree analysis.
Link RE; Allaf ME; Pili R; Kavoussi LR
J Clin Oncol; 2005 Aug; 23(24):5762-73. PubMed ID: 16110033
[TBL] [Abstract][Full Text] [Related]
35. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
Carver BS; Shayegan B; Serio A; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2007 Mar; 25(9):1033-7. PubMed ID: 17261854
[TBL] [Abstract][Full Text] [Related]
36. [Unusual development of nonseminomatous germ cell tumors of the testis (NSGCT)].
Caty A; Depadt G; Feutry ML
Bull Cancer; 1997 Aug; 84(8):796-9. PubMed ID: 9339184
[TBL] [Abstract][Full Text] [Related]
37. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
Amato RJ; Ro JY; Ayala AG; Swanson DA
Urology; 2004 Jan; 63(1):144-8; discussion 148-9. PubMed ID: 14751368
[TBL] [Abstract][Full Text] [Related]
38. Testicular germ cell tumors.
Bridges B; Hussain A
Curr Opin Oncol; 2007 May; 19(3):222-8. PubMed ID: 17414640
[TBL] [Abstract][Full Text] [Related]
39. Advances in the management of testicular cancer.
Ellis M; Sikora K
Drugs Exp Clin Res; 1986; 12(1-3):219-31. PubMed ID: 2426072
[TBL] [Abstract][Full Text] [Related]
40. Interdisciplinary consensus on diagnosis and treatment of testicular germ cell tumors: result of an update conference on evidence-based medicine (EBM).
Krege S; Souchon R; Schmoll HJ;
Eur Urol; 2001 Oct; 40(4):372-91. PubMed ID: 11713391
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
